| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2025 | Feb 10, 2025 | Neuronetics, Inc. | Director | Buy | 95.0 | +88,888 | 19.62% | ✗ | $200K |
| Sep 12, 2024 | Sep 13, 2024 | Neuronetics, Inc. | Director | Buy | 95.0 | +100,000 | 28.32% | ✗ | $75K |
| Aug 16, 2024 | Aug 19, 2024 | Neuronetics, Inc. | Director | Buy | 91.3 | +39,000 | 12.42% | ✗ | $41.7K |
| Aug 14, 2024 | Aug 16, 2024 | Neuronetics, Inc. | Director | Buy | 95.0 | +70,000 | 28.68% | ✗ | $58.5K |
| Jun 6, 2024 | Jun 6, 2024 | Neuronetics, Inc. | Director | Buy | 95.0 | +50,000 | 25.76% | ✗ | $102.6K |
| Aug 10, 2023 | Sep 20, 2023 | Neuronetics, Inc. | Director | Buy | 95.0 | +28,500 | 21.21% | ✗ | $51.7K |
| Aug 16, 2023 | Aug 17, 2023 | KORU Medical Systems, Inc. | Director | Buy | 91.3 | +19,000 | 84.53% | ✗ | $49.5K |
| Nov 22, 2021 | Nov 24, 2021 | Neuronetics, Inc. | Director | Buy | 95.0 | +15,000 | 59.39% | ✗ | $61.5K |
| Aug 30, 2021 | Aug 31, 2021 | Neuronetics, Inc. | Director | Buy | 95.0 | +15,000 | 146.27% | ✗ | $100.8K |